$2.7M sweet spot round size
Most of their 4 investments are in rounds between $250K and $3.4M
2017
Celeris Therapeutics raised $3.4M on February 10, 2022
Investors: Pace Ventures, Longevitytech.fund, R42 Group and i&i Prague
PEP-Therapy raised $1.9M on July 19, 2021
Investors: Anaxago and i&i Prague
Elphogene, s.r.o. raised $250K on April 5, 2019
Investors: i&i Prague
Dracen Pharmaceuticals, Inc. raised $40M on March 22, 2018
Investors: Osage University Partners (OUP) and i&i Prague